511Tip A Phase III, Multicenter, Open-Label, Randomized Study to Assess the Efficacy and Safety of Cetuximab Plus Capecitabine Versus Cetuximab As Maintenance Treatment Following First-Line Induction Treatment with FOLFOX and Cetuximab in Chinese Patients with RAS and BRAF WT Mcrc
ANNALS OF ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined